Deutsches Primatenzentrum (DPZ), Leibniz-Institut für Primatenforschung

Research facility


Location: Göttingen, Germany (DE) DE

ISNI: 0000000085027018

ROR: https://ror.org/02f99v835

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Kaposi’s sarcoma-associated herpesvirus glycoprotein K8.1 is critical for infection in a cell-specific manner and functions at the attachment step on keratinocytes (2023) Liu S, Großkopf AK, Yang X, Mannheim ME, Backovic M, Scribano S, Schlagowski S, et al. Journal article Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3 (2023) Zhang L, Kempf A, Nehlmeier I, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz S, et al. Journal article Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage (2023) Arora P, Cossmann A, Schulz S, Ramos GM, Stankov MV, Jäck HM, Behrens GM, et al. Journal article Comparison of a Genotype 1 and a Genotype 2 Macaque Foamy Virus env Gene Indicates Distinct Infectivity and Cell-Cell Fusion but Similar Tropism and Restriction of Cell Entry by Interferon-Induced Transmembrane Proteins (2023) Fricke T, Schlagowski S, Liu S, Yang X, Fiebig U, Kaul A, Enßer A, Hahn AS Journal article Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage (2023) Nehlmeier I, Kempf A, Arora P, Cossmann A, Dopfer-Jablonka A, Stankov MV, Schulz S, et al. Journal article Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5 (2023) Hoffmann M, Arora P, Nehlmeier I, Kempf A, Cossmann A, Schulz S, Morillas Ramos G, et al. Journal article Omicron sublineage BQ.1.1 resistance to monoclonal antibodies (2023) Arora P, Kempf A, Nehlmeier I, Schulz S, Jäck HM, Pöhlmann S, Hoffmann M Journal article In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant (2022) Heinen N, Marheinecke CS, Bessen C, Blazquez-Navarro A, Roch T, Stervbo U, Anft M, et al. Journal article The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages (2022) Arora P, Zhang L, Nehlmeier I, Kempf A, Cossmann A, Dopfer-Jablonka A, Schulz SR, et al. Journal article Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1 (2022) Sidarovich A, Krueger N, Rocha C, Graichen L, Kempf A, Nehlmeier I, Lier M, et al. Journal article